Merck & Co., Inc: Kidney Failure, Chronic trials
The registry lists 12 Kidney Failure, Chronic studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 10Phase 2 1Phase 3 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)CompletedNCT05769595Phase 1Results posted
- A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)CompletedNCT05656040Phase 1Results posted
- MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)CompletedNCT05335005Phase 1Results posted
- Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)CompletedNCT05027074Phase 2Results posted
- A Study of Belzutifan (MK-6482) in Participants With Renal Impairment (MK-6482-021)CompletedNCT04994522Phase 1Results posted
- Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)CompletedNCT03873038Phase 1Results posted
- Study to Evaluate Daptomycin Given During Dialysis and After DialysisCompletedNCT00882557Phase 1Results posted
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)CompletedNCT00509236Phase 3Results posted
- A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)CompletedNCT07348237Phase 1
- A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)CompletedNCT06814132Phase 1
- Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)CompletedNCT00490737Phase 1
- A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)CompletedNCT00418366Phase 1